These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24429130)

  • 1. Smoking cessation in patients with respiratory disease: existing treatments and future directions.
    Rigotti NA
    Lancet Respir Med; 2013 May; 1(3):241-50. PubMed ID: 24429130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing tobacco use: the neglected cardiovascular disease risk factor.
    Rigotti NA; Clair C
    Eur Heart J; 2013 Nov; 34(42):3259-67. PubMed ID: 24014389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco Cessation Strategies: It Takes a Village.
    Chiu Qua DA
    S D Med; 2017 Spec; Spec No():54-58. PubMed ID: 28817864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA; Lovato P; Cuesta G
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
    Jiménez Ruiz CA; Ramos Pinedo A; Cicero Guerrero A; Mayayo Ulibarri M; Cristobal Fernández M; Lopez Gonzalez G
    Nicotine Tob Res; 2012 Sep; 14(9):1035-9. PubMed ID: 22345320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoking cessation intervention: an evidence-based approach.
    Laniado-Laborín R
    Postgrad Med; 2010 Mar; 122(2):74-82. PubMed ID: 20203458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking cessation.
    Marlow SP; Stoller JK
    Respir Care; 2003 Dec; 48(12):1238-54; discussion 1254-6. PubMed ID: 14651764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cessation in the use of tobacco - pharmacologic and non-pharmacologic routines in patients.
    Quist-Paulsen P
    Clin Respir J; 2008 Jan; 2(1):4-10. PubMed ID: 20298298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation in chronic obstructive pulmonary disease.
    Tashkin DP; Murray RP
    Respir Med; 2009 Jul; 103(7):963-74. PubMed ID: 19285850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Linden K; Jormanainen V; Linna M; Sintonen H; Wilson K; Kotomäki T
    Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Smoking cessation in smokers with chronic obstructive pulmonary disease].
    Underner M; Perriot J; Peiffer G
    Rev Mal Respir; 2014 Dec; 31(10):937-60. PubMed ID: 25496790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic approaches to smoking cessation in the cardiac setting.
    Reid RD; Mullen KA; Pipe AL
    Curr Opin Cardiol; 2011 Sep; 26(5):443-8. PubMed ID: 21730824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy.
    Tønnesen P; Carrozzi L; Fagerström KO; Gratziou C; Jimenez-Ruiz C; Nardini S; Viegi G; Lazzaro C; Campell IA; Dagli E; West R
    Eur Respir J; 2007 Feb; 29(2):390-417. PubMed ID: 17264326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of patients with COPD in three motivational stages related to smoking cessation.
    Hilberink SR; Jacobs JE; Schlösser M; Grol RP; de Vries H
    Patient Educ Couns; 2006 Jun; 61(3):449-57. PubMed ID: 16157462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD?
    Kotz D; Huibers MJ; West RJ; Wesseling G; van Schayck OC
    Patient Educ Couns; 2009 Jul; 76(1):16-24. PubMed ID: 19150590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice.
    Rovina N; Nikoloutsou I; Katsani G; Dima E; Fransis K; Roussos C; Gratziou C
    Ther Adv Respir Dis; 2009 Dec; 3(6):279-87. PubMed ID: 19934280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation: an update.
    Kumar R; Prasad R
    Indian J Chest Dis Allied Sci; 2014; 56(3):161-9. PubMed ID: 25823111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.